Financials
- Market Capitalization 968.53 M
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.27
ratio cours/chiffre d'affaires
13.5
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2484 | ANRO Alto Neuroscience, Inc. Common Stock | 28.03 USD | +5.93% | +5.34% | +30.25% | +930.51% | 983.68 M USD | ||
| 2486 | VOR Vor Biopharma Inc. - Common Stock | 18.03 USD | -5.80% | -10.74% | +22.24% | +37.63% | 976.97 M USD | ||
| 2497 | PHAR Pharming Group N.V. - ADS, each representing 10 | 13.75 USD | +0.22% | -4.71% | +4.56% | +31.96% | 964.81 M USD | ||
| 2498 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.17 USD | -2.25% | -6.47% | +11.28% | +82.35% | 963.91 M USD |